Navigation Links
GenVec Reports Fourth Quarter and 2011 Year-End Financial Results
Date:3/15/2012

vaccines against FMD, to explore applications of our technology in other areas of animal health.
  • We entered into a Cooperative Research and Development Agreement with the U.S. Naval Medical Research Center (NMRC) to support their dengue fever vaccine research. Under a separate contract with the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., GenVec will receive funding for the development and preparation of vaccines related to this program.
  • We completed a reverse stock split and regained compliance with NASDAQ listing requirements.
  • Adel A.F. Mahmoud, M.D., Ph.D. and Edward M. Connor, Jr., M.D. were elected to the Company's Board of Directors adding to the Board's depth of knowledge in the areas of infectious disease and vaccine development.
  • Through our collaboration with the Department of Homeland Security (DHS), we completed a field safety study of our foot-and-mouth disease (FMD) vaccine.

  • 2011 Financial ResultsRevenue increased 8% to $17.7 million in 2011 from $16.5 million in 2010. The increase in 2011 is primarily due to increased revenue of $2.2 million and $1.1 million generated by our hearing loss and balance disorders and foot and mouth disease programs, respectively.  We entered into a collaboration agreement with Novartis in January 2010, which accounted for $3.8 million and $3.4 million of revenue in 2011 and 2010, respectively, and a development agreement related to the supply of clinical trial material related to activities under the collaboration agreement in August 2010, which accounted for $6.0 million and $4.4 million in revenue in 2011 and 2010, respectively.  Work scope under the two Novartis agreements resulted in increased revenue in 2011 as compared to 2010. Increased revenue associated with our foot and mouth disease program is due mainly to an increase in work scope under our agreements with the DHS.  Partially offsetting the increased revenue associated
    '/>"/>

    SOURCE GenVec, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. GenVec President and Chief Executive Officer Announces Retirement
    2. GenVec Achieves Second Milestone in Collaboration
    3. GenVec to Present at the 2011 10th Annual BIO Investor Forum
    4. GenVec Renews Stockholder Rights Plan
    5. GenVec Reports First Quarter 2011 Financial Results
    6. GenVec Regains Compliance with NASDAQ Listing Requirements
    7. GenVec, Inc. Announces Effectiveness of Reverse Stock Split
    8. GenVec To Host Fourth Quarter and Year-End 2010 Earnings Call and Webcast
    9. GenVec to Present at the 13th Annual BIO CEO & Investor Conference
    10. Merriman Curhan Ford Acted as Placement Agent in GenVecs $28 Million Registered Offering
    11. GenVec Reports Third Quarter 2009 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... ... 28, 2015 , ... Since the initial launch of FireflySci Inc. (FFS) in early 2015, the ... service. Images such as the Fonz in a lab coat and Large Marge have ... humdrum spectroscopy field. , FireflySci is proud to be the only cuvette manufacturer ...
    (Date:8/27/2015)... , ... August 27, 2015 , ... Capital Edge ... complex business problems, is pleased to announce their ranking as one of the top ... of the fastest-growing private companies across the nation. , “It is truly an honor ...
    (Date:8/27/2015)... Aug. 27, 2015 /PRNewswire/ - Portage Biotech Inc. ... and Biohaven Pharmaceutical Holding Company Limited (Biohaven), announced ... I study of BHV-0223, a glutamate modulating agent. ... BHV-0223 and recently obtained clearance from the U.S. ... human testing. Portage holds 54% equity interest in ...
    (Date:8/27/2015)... PARK, Calif. , Aug. 27, 2015  Asterias ... in the emerging field of regenerative medicine, today announced ... investor conferences in the month of September.  ... will present at Rodman & Renshaw,s 17th Annual Global ... ET/7:25am PT at the St. Regis Hotel in ...
    Breaking Biology Technology:Cuvette Manufacturer FireflySci Launches Back to School Deals with Complimentary Shipping On All Orders 2Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 2Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4Asterias Biotherapeutics to Present at Upcoming Investor Conferences 2
    ... David Batey, Ph.D., , ... Real-time quantification was performed for lambda and human genomic ... DNA polymerase*,was used for amplification, and SYBR Green I fluorescent dye was used ... for ranges,of 100 to 1x10 8 initial copies of lambda DNA and ...
    ... Surekha Karudapuram, Ph.D. and David Batey Ph.D. ... San Francisco, CA , , ... A two-color real-time quantitative PCR (qPCR) protocol was ... genotype the CYP2D6*4 allele in 211,patient samples. Two hydrolysis probes, one labeled with ...
    ... Hans-Peter Horz, Ph.D.1, Richard Kurtz, Ph.D.2, David Batey, Ph.D.2 , ... 1Department of Biological Sciences, Stanford University, Stanford, CA , ... Francisco, CA , , ... The levels of the amoA gene were used to measure the ammonia-oxidizing bacteria (AOB) population ...
    Cached Biology Technology:Real-Time Quantification of Genomic DNA Using DyNAzyme II DNA Polymerase and SYBR Green I Dye 2Real-Time Quantification of Genomic DNA Using DyNAzyme II DNA Polymerase and SYBR Green I Dye 3Real-Time Quantification of Genomic DNA Using DyNAzyme II DNA Polymerase and SYBR Green I Dye 4Real-Time Quantification of Genomic DNA Using DyNAzyme II DNA Polymerase and SYBR Green I Dye 5Real-Time Quantification of Genomic DNA Using DyNAzyme II DNA Polymerase and SYBR Green I Dye 6Real-Time Quantification of Genomic DNA Using DyNAzyme II DNA Polymerase and SYBR Green I Dye 7Real-Time Quantification of Genomic DNA Using DyNAzyme II DNA Polymerase and SYBR Green I Dye 8Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System 2Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System 3Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System 4Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System 5Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System 6Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System 7Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System 2Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System 3Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System 4Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System 5Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System 6Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System 7
    (Date:8/11/2015)... , August 11, 2015 Today, ZUK ... Already received as well as expected revenues in 2015 that relate ... FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a prominent smartphone manufacturer in ... ZUK selected FPC1 155 for ...
    (Date:8/6/2015)... 2015  Today, U.S. Congressman Mike Honda ... to learn firsthand how Silicon Valley technologies can ... a world leader in multi-factor identity management and ... federal agencies and commercial organizations achieve new levels ... "The vast majority of network breaches can be ...
    (Date:8/5/2015)... August 5, 2015 According to ... Management Market by Software, Services, Vertical (BFSI, Airport, IT & ... - Global Forecast to 2020", published by MarketsandMarkets, defines ... globally into various segments. The global PIAM Market is ... $546.2 Million by 2019, at a CAGR of 14.9 ...
    Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2Rep. Honda to Visit Crossmatch in Redwood City 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4
    ... laser scanning confocal microscope (LSCM) holds the promise of ... take 3-D images of thick tissue samples by visualizing ... time. Sometimes scientists supplement these microscopes with spectrographs, which ... "colors," in the light reflected off of a piece ...
    ... Illinois scientists have engineered a new strain of yeast that ... just months ago. That,s a process that,s important outside the ... professor of microbial genomics and a faculty member in its ... ability to ferment cellobiose and galactose simultaneously, which makes the ...
    ... from Wake Forest University has advanced the field ... first time, an extremely large molecule that is ... produce. The technology, developed by Oana ... her graduate students Katelyn Goetz and Jeremy Ward, ...
    Cached Biology News:Illinois-UC Berkeley discovery turns seaweed into biofuel in half the time 2Flexible electronics hold promise for consumer applications 2
    Polyclonal Antibody to CRTR-1...
    Recognizes NSCL1. The molecular weight of the protein is 14,616 Daltons....
    Mouse monoclonal [3G131] to Desmoglein 1 ( Abpromise for all tested applications). entrezGeneID: 1828 SwissProtID: Q02413...
    Mouse monoclonal [2D7/1] to E.coli LPS ( Abpromise for all tested applications). Antigen: Tissue / cell preparation: Escherichia coli J5 cells....
    Biology Products: